Valuation : Divi's Laboratories Limited

Market Cap 2,456B 25.98B 22.35B 20.97B 19.19B 35.82B 36.1B 248B 96.63B 1,255B 97.55B 95.42B 4,042B P/E 2027 *
75.3x
P/E 2028 * 62.5x
Enterprise Value 2,421B 25.61B 22.03B 20.67B 18.92B 35.31B 35.59B 245B 95.25B 1,237B 96.16B 94.06B 3,984B EV / Sales 2027 *
19.2x
EV / Sales 2028 * 16.1x
Free-Float
48.01%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day-0.68%
1 week-0.56%
Current month-2.96%
1 month+9.66%
3 months+39.27%
6 months+45.46%
Current year+43.72%
1 week 9,087
Extreme 9087
9,467
1 month 8,233.5
Extreme 8233.5
9,467
Current year 5,647.5
Extreme 5647.5
9,467
1 year 5,636.5
Extreme 5636.5
9,467
3 years 3,295.3
Extreme 3295.3
9,467
5 years 2,730
Extreme 2730
9,467
10 years 532.65
Extreme 532.65
9,467
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-0.69%-0.56%+49.78%+153.13% 25.98B
-0.04%-1.40%+57.16%+108.15% 1,034B
+1.17%+4.76%+56.42%+73.50% 671B
-0.58%+0.80%+22.82%+75.58% 460B
+2.09%-2.06%+32.28%+37.41% 353B
0.00%+5.36%+27.40%+46.97% 309B
+1.42%+0.26%-0.52%+13.51% 255B
+0.29%+1.63%+56.46%+73.00% 240B
-0.03%+2.13%-17.30%-53.65% 207B
+1.08%+1.59%+33.83%+97.29% 188B
Average +0.42%+1.36%+31.83%+62.49% 374.27B
Weighted average by Cap. +0.34%+1.05%+38.68%+68.31%

Financials

2027 *2028 *
Net sales 126B 1.33B 1.14B 1.07B 983M 1.83B 1.85B 12.71B 4.95B 64.26B 5B 4.89B 207B 150B 1.59B 1.36B 1.28B 1.17B 2.19B 2.2B 15.15B 5.9B 76.61B 5.95B 5.83B 247B
Net income 32.65B 345M 297M 279M 255M 476M 480M 3.3B 1.28B 16.68B 1.3B 1.27B 53.74B 39.42B 417M 359M 337M 308M 575M 579M 3.98B 1.55B 20.14B 1.57B 1.53B 64.88B
Net Debt -35B -370M -319M -299M -274M -510M -515M -3.54B -1.38B -17.89B -1.39B -1.36B -57.6B -44.85B -474M -408M -383M -351M -654M -659M -4.53B -1.76B -22.92B -1.78B -1.74B -73.82B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
04/09/26 9,186.50 -0.69% 69,577
03/09/26 ₹9,250.00 +0.33% 497,269
02/09/26 ₹9,220.00 +0.60% 403,619
01/09/26 ₹9,165.00 -3.19% 485,620
31/08/26 ₹9,467.00 +2.47% 680,805
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,250.00INR
Average target price
8,447.00INR
Spread / Average Target
-8.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock